Biotech News
Related news
PGNYProgyny2026-01-12 13:00 EST
Progyny to Discuss Updated Financial Expectations at Upcoming JP Morgan Healthcare Conference
PGNYProgyny2025-11-13 17:33 EST
Progyny, Inc. to Present at Jefferies Global Healthcare Conference
TDOCTeladoc2026-03-30 20:30 EST
Teladoc Health Appoints Susan Salka, Experienced Healthcare Executive, to Its Board of Directors
MGRXMANGOCEUTICALS2025-12-19 12:30 EST
Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy
TDOCTeladoc2026-07-23 10:00 EST
Teladoc Health introduces a virtual care practice built around the person, shaping a new era of connected care
SERASera Prognostics2026-06-24 20:05 EST
SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH
HSTMHealthStream2026-03-26 13:25 EST
Virsys12® Named a Leader in the IDC MarketScape: U.S. Provider Data Management for Payers 2025–2026 Vendor Assessment
FEMYFEMASYS2026-02-23 14:00 EST
Femasys Receives AMA CPT Editorial Panel Approval for New Category III CPT Code for FemaSeed Intratubal Insemination
COOThe Cooper Companies2025-12-29 21:15 EST
CooperCompanies to Present at the J.P. Morgan Healthcare Conference
COOThe Cooper Companies2025-08-14 20:15 EST
CooperCompanies to Participate in the Wells Fargo Healthcare Conference
Progyny
Women's Health and Family Building Progyny manages employer-sponsored benefits for fertility, family building and women's health. Its programs are designed to guide members through complex care while helping benefit purchasers manage quality and cost. Integrated Benefit Platform The company's services include fertility treatment,...
Recent company news
PGNYProgyny2026-08-07 14:51 EST
Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference
PGNYProgyny2026-08-06 20:01 EST
Progyny, Inc. Announces Second Quarter 2026 Results
PGNYProgyny2026-07-23 19:30 EST
Progyny, Inc. Announces Details for Its Second Quarter 2026 Results Report
PGNYProgyny2026-05-28 13:04 EST
New Progyny Study Shows Growing Demand for Human Guidance in an Increasingly Digital Healthcare System
PGNYProgyny2026-05-26 12:00 EST
Progyny, Inc. Announces Share Repurchase Program
Stock data
- Close
- 30.21 USD
- Market cap
- 1.97B USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
